Benchmarking: Clinical Trials

7 trials of Benchmarking, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting, 1 terminated. 7 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 5, Active not recruiting 1, Terminated 1
Phase 11Completed 1

Follow Benchmarking: new trials by email Literature Review of Benchmarking trials Research Report on Benchmarking

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
Biopsy, Fecal Microbiota Transplantation, Fecal Microbiota Transplantation Capsule - Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma
Phase 2Active not recruitingM.D. Anderson Cancer Center152021-02-222026-06-12
Prevention of Dry Socket by Means of Single Preoperative Antibiotics Compared to Conventional Therapy
Amoxicillin 500 Mg, metronidazole 400mg, metronidazol 400mg and amoxicillin 500mg - Dry Socket
Phase 2CompletedDow University of Health Sciences2252018-10-012019-06-20
Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
RIFAXIMIN VAGINAL TABLET 25 MG, RIFAXIMIN VAGINAL TABLET 100 MG, PLACEBO VAGINAL TABLET - BACTERIAL VAGINOSIS
Phase 2TerminatedAlfasigma S.p.A.3922015-04-012016-10-10
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
BFH772 1% ointment, Vehicle ointment, Noritate® 1% cream - Erythemato-telangiectatic Rosacea
Phase 2CompletedNovartis Pharmaceuticals362011-09-012021-02-21
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer
Sargramostim (GM-CSF, Leukine), Flutamide (Eulexin), PROSTVAC-F/ TRICOM - Prostate Cancer
Phase 2CompletedNational Cancer Institute (NCI)642007-02-232018-11-29
Study of Conservative Versus Surgical Treatment of Appendicitis
cefotaxim and metronidazol - Appendicitis
Phase 2CompletedGöteborg University3602006-05-012009-04-21
Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
Metronidazole - Bacterial Vaginosis
Phase 1 / Phase 2CompletedTeva Pharmaceuticals USA5792002-01-012024-08-19

Conditions studied

Vaginosis, Bacterial (2)  ·  Appendicitis (1)  ·  Colorectal Neoplasms (1)  ·  Dry Socket (1)  ·  Prostatic Neoplasms (1)  ·  Rosacea (1)  ·  Vaginal Diseases (1)

Sponsors

Alfasigma S.p.A. (1)  ·  Dow University of Health Sciences (1)  ·  Göteborg University (1)  ·  M.D. Anderson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Novartis Pharmaceuticals (1)  ·  Teva Pharmaceuticals USA (1)

Countries

United States (5)  ·  Pakistan (1)  ·  Sweden (1)

Top investigators

Kent Lundholm (1)  ·  Michael J Overman (1)  ·  Raffaella Tacchi, MD (1)  ·  Ravi A Madan, M.D. (1)

Results publications

PMID 19358184, PMID 37134294

NIH funding

P50CA221707 (1)